(VIANEWS) – Another day of trading has ended and here’s today’s list of stocks that have had significant trading activity in the Euronext session.

The three biggest winners today are NORTHERN DRILLING, ORPEA, and SODITECH.

Financial Asset	Price	Change	Updated (EST)
NORTHERN DRILLING (NODL.OL)	4.42	82.64%	2023-11-28 12:41:34
ORPEA (ORP.PA)	0.24	15.64%	2023-11-28 13:21:03
SODITECH (SEC.PA)	1.70	14.09%	2023-11-28 13:22:57
HOTELS DE PARIS (HDP.PA)	3.16	10.49%	2023-11-28 13:04:48
EUROCASTLE INVEST. (ECT.AS)	8.65	8.12%	2023-11-28 12:02:00
NEPI ROCKCASTLE (NRP.AS)	5.55	7.77%	2023-11-28 12:03:05
ATEME (ATEME.PA)	7.00	7.69%	2023-11-28 12:45:50
EASE2PAY NV (EAS2P.AS)	0.59	6.93%	2023-11-28 12:01:43
IDEX BIOMETRICS (IDEX.OL)	0.56	5.84%	2023-11-28 12:40:35
VISTIN PHARMA (VISTN.OL)	22.60	4.63%	2023-11-28 12:44:06

The three biggest losers today are HAVILA SHIPPING, AVANCE GAS HOLDING, and ARGENX SE.

Financial Asset	Price	Change	Updated (EST)
HAVILA SHIPPING (HAVI.OL)	5.00	-13.79%	2023-11-28 12:40:22
AVANCE GAS HOLDING (AGAS.OL)	155.00	-11.53%	2023-11-28 12:24:58
ARGENX SE (ARGX.BR)	404.80	-10.86%	2023-11-28 12:04:52
CNOVA (CNV.PA)	1.30	-10.34%	2023-11-28 13:01:17
PIERRE VAC BSA ACT (VACBS.PA)	0.15	-9.76%	2023-11-28 13:21:25
SOLOCAL GROUP (LOCAL.PA)	0.09	-8.81%	2023-11-28 13:23:03
UBISOFT ENTERTAIN (UBI.PA)	27.08	-7.95%	2023-11-28 13:24:04
NEL (NEL.OL)	7.22	-7.88%	2023-11-28 12:41:22
BENEVOLENTAI (BAI.AS)	0.60	-7.69%	2023-11-28 12:00:59
CARASENT (CARA.OL)	10.38	-7.65%	2023-11-28 12:25:31

Winners today

1. NORTHERN DRILLING (NODL.OL)

82.64% Price Change

Northern Drilling Ltd. operates as an offshore drilling contractor to the oil and gas industry. The company primarily engages in acquiring and operating offshore drilling assets, as well as involved in drilling in ultra-deep water environments. Northern Drilling Ltd. was incorporated in 2017 and is based in Hamilton, Bermuda.

Oslo Børs Benchmark Index_GI ended the session with NORTHERN DRILLING jumping 82.64% to €4.42 on Tuesday while Oslo Børs Benchmark Index_GI dropped 0.87% to €1,299.85.

Earnings Per Share

As for profitability, NORTHERN DRILLING has a trailing twelve months EPS of kr-6.11.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -4.22%.

Volume

Today’s last reported volume for NORTHERN DRILLING is 15639100 which is 1159.94% above its average volume of 1241250.

Volatility

NORTHERN DRILLING’s last week, last month’s, and last quarter’s current intraday variation average was 27.34%, 1.39%, and 9.47%.

NORTHERN DRILLING’s highest amplitude of average volatility was 27.34% (last week), 16.16% (last month), and 9.47% (last quarter).

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, NORTHERN DRILLING’s stock is considered to be oversold (<=20).

Moving Average

NORTHERN DRILLING’s worth is way under its 50-day moving average of kr5.29 and way below its 200-day moving average of kr22.66.

More news about NORTHERN DRILLING.

2. ORPEA (ORP.PA)

15.64% Price Change

ORPEA SA operates nursing homes, assisted-living facilities, post-acute and rehabilitation hospitals, and psychiatric hospitals. Its nursing home facilities provide personalized support services; and logistical and residential services, including accommodation, meals, and laundry and room cleaning, as well as various daily event, entertainment, and therapeutic workshop services. The company's post-acute and rehabilitation hospitals offer services for geriatrics, musculoskeletal, nervous system, cardiovascular, hematology, and oncology conditions, as well as patients in a persistent vegetative state or in a minimally conscious state. Its psychiatric hospitals provide services for the patients with mood disorders, anxiety disorders, obsessive-compulsive disorders, addictions, eating disorders, sleep disorders, personality disorders, ageing-related psychiatric disorders, psychosis, over exhaustion or burn-out, chronic fatigue syndrome, fibromyalgia, psychosomatic conditions, and post-traumatic stress disorder conditions, as well as geriatric, child, young adult, parent-child, and public/private patients psychiatry services. In addition, the company offers home care services, including housekeeping services, such as cleaning, meals, ironing, gardening, and household errands; daily life assistance services comprising day or night supervision, assistance with hygiene tasks, and meal-time assistance; and movement assistance services. The company operates in France, Belgium, Spain, Italy, Ireland, Switzerland, Austria, Germany, the Czech Republic, Poland, the Netherlands, Luxembourg, Portugal, Brazil, Russia, Slovenia, Uruguay, Colombia, Mexico, Chile, Latvia, Croatia, and China. ORPEA SA was founded in 1989 and is headquartered in Puteaux, France.

CAC 40 ended the session with ORPEA jumping 15.64% to €0.24 on Tuesday, after five sequential sessions in a row of losses. CAC 40 fell 0.21% to €7,250.13, following the last session’s downward trend on what was a somewhat down trend exchanging session today.

Earnings Per Share

As for profitability, ORPEA has a trailing twelve months EPS of €-4.11.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -445.48%.

Yearly Top and Bottom Value

ORPEA’s stock is valued at €0.24 at 21:40 EST, way under its 52-week high of €8.93 and way above its 52-week low of €0.06.

More news about ORPEA.

3. SODITECH (SEC.PA)

14.09% Price Change

Soditech SA engages in the integration of mechanical, thermal, and electronic sub-assemblies in space, research, and defense fields in France. It designs structural sub-assemblies and integrates optical and thermal equipment, such as OSRs, SSMs, heaters, and heat pipes; designs and manufactures multi-layer insulation products; and designs, manufactures, and tests space harnesses on instruments or platforms. The company also provides calculation services, such as static, dynamic, thermal, and thermoelastic; designs assembly tools; and designs and produces super insulating multi-layer mattresses for ultra-vacuum areas. In addition, it develops, qualifies, manufactures, and tests embedded cabinets; and designs, assembles, and tests racks and test equipment racks. The company was formerly known as Soditech Ingenierie SA. Soditech SA was founded in 1990 and is headquartered in Aix-en-Provence, France.

CAC 40 ended the session with SODITECH jumping 14.09% to €1.70 on Tuesday while CAC 40 fell 0.21% to €7,250.13.

Earnings Per Share

As for profitability, SODITECH has a trailing twelve months EPS of €0.07.

PE Ratio

SODITECH has a trailing twelve months price to earnings ratio of 24.29. Meaning, the purchaser of the share is investing €24.29 for every euro of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 11.54%.

Revenue Growth

Year-on-year quarterly revenue growth declined by 12.7%, now sitting on 4.59M for the twelve trailing months.

Moving Average

SODITECH’s worth is way higher than its 50-day moving average of €1.51 and way above its 200-day moving average of €1.52.

More news about SODITECH.

4. HOTELS DE PARIS (HDP.PA)

10.49% Price Change

Les Hôtels de Paris SA operates and manages hotels in Paris. It also offers restaurant and bar services. The company operates hotels in Paris, St Tropez, and Marrakech. Les Hôtels de Paris SA was incorporated in 1992 and is headquartered in Paris, France.

CAC 40 ended the session with HOTELS DE PARIS jumping 10.49% to €3.16 on Tuesday, following the last session’s upward trend. CAC 40 dropped 0.21% to €7,250.13, following the last session’s downward trend on what was a somewhat negative trend exchanging session today.

Earnings Per Share

As for profitability, HOTELS DE PARIS has a trailing twelve months EPS of €-0.4.

Volume

Today’s last reported volume for HOTELS DE PARIS is 38 which is 94.27% below its average volume of 664.

Dividend Yield

As claimed by Morningstar, Inc., the next dividend payment is on Jan 1, 1970, the estimated forward annual dividend yield is 1.69%.

More news about HOTELS DE PARIS.

5. EUROCASTLE INVEST. (ECT.AS)

8.12% Price Change

Eurocastle Investment Limited is a publicly traded closed-ended investment company that focuses on investing in performing and nonperforming loans and other real estate related assets primarily in Italy. The Company is Euro denominated and is listed on Euronext Amsterdam under the symbol “ECT”. Eurocastle is managed by an affiliate of Fortress Investment Group LLC, a leading global investment manager. For more information regarding Eurocastle Investment Limited and to be added to our email distribution list, please visit www.eurocastleinv.com.

AEX-Index ended the session with EUROCASTLE INVEST. jumping 8.12% to €8.65 on Tuesday, after two sequential sessions in a row of gains. AEX-Index fell 0.37% to €761.37, following the last session’s downward trend on what was a somewhat negative trend exchanging session today.

Earnings Per Share

As for profitability, EUROCASTLE INVEST. has a trailing twelve months EPS of €-0.68.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -3.2%.

Volume

Today’s last reported volume for EUROCASTLE INVEST. is 2 which is 94.11% below its average volume of 34.

Yearly Top and Bottom Value

EUROCASTLE INVEST.’s stock is valued at €8.65 at 21:40 EST, way below its 52-week high of €10.70 and way higher than its 52-week low of €6.00.

Volatility

EUROCASTLE INVEST.’s last week, last month’s, and last quarter’s current intraday variation average was 10.49%, 2.12%, and 5.55%.

EUROCASTLE INVEST.’s highest amplitude of average volatility was 10.49% (last week), 8.37% (last month), and 5.55% (last quarter).

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, EUROCASTLE INVEST.’s stock is considered to be oversold (<=20).

More news about EUROCASTLE INVEST..

6. NEPI ROCKCASTLE (NRP.AS)

7.77% Price Change

NEPI Rockcastle is the premier owner and operator of shopping centres in Central and Eastern Europe (CEE), with presence in nine countries and an investment portfolio of €5.8 billion as at 31 December 2021. The Group benefits from a highly-skilled internal management team which combines asset management, development, investment, leasing and financial expertise. Geographically diverse management skills allow NEPI Rockcastle to pursue CEE property opportunities efficiently, benefiting from a strategic advantage in the acquisition, development and management of properties. NEPI Rockcastle owns and operates 52 retail properties (excluding joint venture) which attracted 244 million visits in 2021 (325 million visits in 2019). With group-level management of tenant relationships and a focus on cross-country collaboration, the Group is the leading strategic partner for major retailers targeting CEE countries. The Group's financial strategy includes maintaining a profile of adequate liquidity, conservative gearing, and a diverse debt structure, which combines secured and unsecured bank debt with unsecured bonds listed on the Irish Stock Exchange. NEPI Rockcastle is investment-grade rated by Standard & Poor's (BBB, stable outlook) and Fitch (BBB, positive outlook). NEPI Rockcastle's shares are listed on the Johannesburg Stock Exchange (“JSE”), Euronext Amsterdam (“Euronext”) and A2X. The Group voluntarily distributes at least 90% of its distributable earnings on a semi-annual basis.

AEX-Index ended the session with NEPI ROCKCASTLE rising 7.77% to €5.55 on Tuesday, after five consecutive sessions in a row of losses. AEX-Index dropped 0.37% to €761.37, following the last session’s downward trend on what was a somewhat negative trend trading session today.

Earnings Per Share

As for profitability, NEPI ROCKCASTLE has a trailing twelve months EPS of €0.85.

PE Ratio

NEPI ROCKCASTLE has a trailing twelve months price to earnings ratio of 6.53. Meaning, the purchaser of the share is investing €6.53 for every euro of annual earnings.

Volume

Today’s last reported volume for NEPI ROCKCASTLE is 5436 which is 182.68% above its average volume of 1923.

More news about NEPI ROCKCASTLE.

7. ATEME (ATEME.PA)

7.69% Price Change

ATEME SA, together with its subsidiaries, provides electronic and computer devices and instruments worldwide. The company offers various solutions, such as TITAN Live, a software-based live video compression for the converged headend; TITAN File, a video transcoding software; TITAN Mux, a multi-function software stream processing solution; KYRION CM5000e, an ultra-low latency encoder; TITAN Edge encoder; TITAN Edge decoder; TITAN Edge gateway; and KYRION DR5000, an ultra-low latency integrated receiver decoder. It also provides NEA-CDN, an OTT scale service solution; NEA-DVR; NEA-Live for immersive viewing experience; NEA-Composer, a dynamic Ad insertion and linear origination solution; PILOT Media, a cloud native media supply chain solution; and PILOT Manager, a cloud native management system. The company serves content providers, service providers, and streaming platforms. ATEME SA was incorporated in 1991 and is headquartered in Vélizy-Villacoublay, France.

CAC 40 ended the session with ATEME jumping 7.69% to €7.00 on Tuesday, following the last session’s upward trend. CAC 40 dropped 0.21% to €7,250.13, following the last session’s downward trend on what was a somewhat down trend exchanging session today.

Earnings Per Share

As for profitability, ATEME has a trailing twelve months EPS of €-0.28.

More news about ATEME.

8. EASE2PAY NV (EAS2P.AS)

6.93% Price Change

Ease2pay N.V. provides online payment services and platforms in the Netherlands. The company operates payment transaction platform, which offers users services to order and pay in one action; and parking solutions. It also operates a platform that connects travelers with providers of parking and charging facilities on the road and water. The company was formerly known as DOCDATA N.V. and changed its name to Ease2pay N.V. in February 2018. Ease2pay N.V. is based in Rotterdam, the Netherlands.

AEX-Index ended the session with EASE2PAY NV rising 6.93% to €0.59 on Tuesday while AEX-Index slid 0.37% to €761.37.

Earnings Per Share

As for profitability, EASE2PAY NV has a trailing twelve months EPS of €-1.15.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -127.61%.

More news about EASE2PAY NV.

9. IDEX BIOMETRICS (IDEX.OL)

5.84% Price Change

IDEX Biometrics ASA, together with its subsidiaries, designs, develops, and sells fingerprint authentication solutions in Norway, Europe, the Middle East, Africa, the Americas, and the Asia-Pacific regions. The company's fingerprint authentication solutions are used primarily in contactless financial payment, access control, and smart cards, as well as card-based devices for the storage of digital currencies. It primarily serves manufacturers of smart cards for financial payment applications and biometric payment card markets. The company was incorporated in 1996 and is headquartered in Oslo, Norway.

Oslo Børs Benchmark Index_GI ended the session with IDEX BIOMETRICS rising 5.84% to €0.56 on Tuesday while Oslo Børs Benchmark Index_GI dropped 0.87% to €1,299.85.

Earnings Per Share

As for profitability, IDEX BIOMETRICS has a trailing twelve months EPS of kr-0.22.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -199.48%.

Yearly Top and Bottom Value

IDEX BIOMETRICS’s stock is valued at kr0.56 at 21:40 EST, way below its 52-week high of kr1.37 and way above its 52-week low of kr0.36.

More news about IDEX BIOMETRICS.

10. VISTIN PHARMA (VISTN.OL)

4.63% Price Change

Vistin Pharma ASA, through its subsidiary, Vistin Pharma AS, produces and sells active pharmaceutical ingredients (APIs) worldwide. It offers metformin HCl APIs and direct compressive granulates for the pharmaceutical industry. The company was founded in 1969 and is headquartered in Oslo, Norway.

Oslo Børs Benchmark Index_GI ended the session with VISTIN PHARMA rising 4.63% to €22.60 on Tuesday, after three consecutive sessions in a row of losses. Oslo Børs Benchmark Index_GI slid 0.87% to €1,299.85, following the last session’s downward trend on what was a somewhat down trend trading session today.

Earnings Per Share

As for profitability, VISTIN PHARMA has a trailing twelve months EPS of kr1.

PE Ratio

VISTIN PHARMA has a trailing twelve months price to earnings ratio of 22.6. Meaning, the purchaser of the share is investing kr22.6 for every norwegian krone of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 16.03%.

Yearly Top and Bottom Value

VISTIN PHARMA’s stock is valued at kr22.60 at 21:40 EST, under its 52-week high of kr25.10 and way above its 52-week low of kr13.40.

Volume

Today’s last reported volume for VISTIN PHARMA is 508 which is 97.88% below its average volume of 24009.

More news about VISTIN PHARMA.

Losers Today

1. HAVILA SHIPPING (HAVI.OL)

-13.79% Price Change

Havila Shipping ASA, together with its subsidiaries, engages in the shipping business. It manages and operates offshore service vessels primarily in Norway, the United Kingdom, Denmark, Belgium, the Netherlands, Iceland, Tunisia, the Marshall Islands, and the United States. The company operates a fleet of 17 vessels, including 2 anchor handling vessels, 11 platform supply vessels, 1 rescue recovery vessel, and 3 subsea vessels. Its anchor handling tug and supply vessels are used for moving rigs and putting out anchors, as well as for supply services; platform supply vessels are used to carry goods, water, drilling mud, chemicals, etc. to and from the offshore installations; subsea vessels are used for under water construction work, as well as for support for under water operations; and rescue recovery vessels are used to offer security services, such as oil spill preparedness, fire protection, rescue operation, and recovery at oil installations. The company was founded in 2003 and is headquartered in Fosnavåg, Norway. Havila Shipping ASA is a subsidiary of Havila Holding AS.

Oslo Børs Benchmark Index_GI ended the session with HAVILA SHIPPING falling 13.79% to €5.00 on Tuesday while Oslo Børs Benchmark Index_GI dropped 0.87% to €1,299.85.

Earnings Per Share

As for profitability, HAVILA SHIPPING has a trailing twelve months EPS of kr-2.45.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 345.66%.

Earnings Before Interest, Taxes, Depreciation, and Amortization

HAVILA SHIPPING’s EBITDA is 2.43.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, HAVILA SHIPPING’s stock is considered to be overbought (>=80).

Volume

Today’s last reported volume for HAVILA SHIPPING is 146150 which is 43.34% above its average volume of 101958.

Moving Average

HAVILA SHIPPING’s value is way under its 50-day moving average of kr8.31 and way below its 200-day moving average of kr12.52.

More news about HAVILA SHIPPING.

2. AVANCE GAS HOLDING (AGAS.OL)

-11.53% Price Change

Avance Gas Holding Ltd, together with its subsidiaries, engages in the transportation of liquefied petroleum gas (LPG). The company transports LPG from the Persian Gulf and the United States Gulf/the United States East Coast to destinations in Europe, South America, India, and Asia. As of December 31, 2022, it owned and operated through a fleet of twelve very large gas carriers and four dual-fuel LPG newbuildings. The company was founded in 2007 and is based in Hamilton, Bermuda. Avance Gas Holding Ltd operates as a subsidiary of Hemen Holding Ltd.

Oslo Børs Benchmark Index_GI ended the session with AVANCE GAS HOLDING sliding 11.53% to €155.00 on Tuesday, following the last session’s downward trend. Oslo Børs Benchmark Index_GI dropped 0.87% to €1,299.85, following the last session’s downward trend on what was a somewhat down trend trading session today.

Earnings Per Share

As for profitability, AVANCE GAS HOLDING has a trailing twelve months EPS of kr16.7.

PE Ratio

AVANCE GAS HOLDING has a trailing twelve months price to earnings ratio of 9.28. Meaning, the purchaser of the share is investing kr9.28 for every norwegian krone of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 17.24%.

Growth Estimates Quarters

The company’s growth estimates for the present quarter and the next is 128.8% and 179.1%, respectively.

Dividend Yield

As maintained by Morningstar, Inc., the next dividend payment is on Jun 7, 2023, the estimated forward annual dividend rate is 21.31 and the estimated forward annual dividend yield is 22.06%.

More news about AVANCE GAS HOLDING.

3. ARGENX SE (ARGX.BR)

-10.86% Price Change

argenx SE, a biotechnology company, engages in the developing of various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany, France, Canada, the United Kingdom, and Italy. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, pemphigus foliaceus, chronic inflammatory demyelinating polyneuropathy, bullous pemphigoid, and idiopathic inflammatory myopathy; and ENHANZE SC. The company is also developing ARGX-109 and ARGX-116; ARGX-117 for severe autoimmune indications; ARGX-118 for airway inflammation; ARGX-119, an antibody that targets muscle-specific tyrosine kinase stage; and ARGX-114, an antibody directed against the mesenchymal-epithelial transition factor receptor. In addition, its partnered product candidates include Cusatuzumab for treatment of acute myeloid leukemia; ARGX-115 for the treatment of cancer; and ARGX-112 to treat interleukin-22 receptor. The company has strategic partnership with AbbVie S.À.R.L., Zai Lab Limited, and LEO Pharma A/S; and collaboration and license agreement with Genor Biopharma Co. Ltd, Université Catholique de Louvain, Sopartec S.A., NYU Langone Health, Leiden University Medical Center, AgomAb Therapeutics NV, Broteio Pharma B.V., VIB vzw, University of Texas, BioWa, Inc., Staten Biotechnology B.V., and Shire International GmbH. It also has collaboration agreement with Genmab A/S to discover, develop, and commercialize novel therapeutic antibodies with applications in immunology and oncology, as well as a strategic collaboration with IQVIA Holdings Inc. to provide safety systems and services. argenx SE was incorporated in 2008 and is based in Amsterdam, the Netherlands.

BEL 20 ended the session with ARGENX SE falling 10.86% to €404.80 on Tuesday while BEL 20 slid 1.55% to €3,505.19.

Earnings Per Share

As for profitability, ARGENX SE has a trailing twelve months EPS of €-3.77.

Volatility

ARGENX SE’s last week, last month’s, and last quarter’s current intraday variation average was 0.21%, 0.16%, and 1.21%.

ARGENX SE’s highest amplitude of average volatility was 1.33% (last week), 1.03% (last month), and 1.21% (last quarter).

More news about ARGENX SE.

4. CNOVA (CNV.PA)

-10.34% Price Change

Cnova N.V. operates as an e-commerce company in France and Western Europe. The company offers home appliances, consumer electronics, computers, home furnishings, and leisure and personal goods through its cdiscount.com website. It also operates Cdiscount Voyages, a travel platform; Cdiscount Mobile for cell phone plans; Cdiscount Advertising, a digital marketing solution; Octopia for turnkey marketplace solutions to retailers and e-merchants; and C-Logistics for transportation and logistics services. The company was founded in 1998 and is headquartered in Amsterdam, the Netherlands. Cnova N.V. is a subsidiary of Casino, Guichard-Perrachon S.A.

CAC 40 ended the session with CNOVA dropping 10.34% to €1.30 on Tuesday while CAC 40 dropped 0.21% to €7,250.13.

Earnings Per Share

As for profitability, CNOVA has a trailing twelve months EPS of €-0.35.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, CNOVA’s stock is considered to be overbought (>=80).

Moving Average

CNOVA’s value is way below its 50-day moving average of €2.13 and way under its 200-day moving average of €3.11.

Revenue Growth

Year-on-year quarterly revenue growth declined by 29.9%, now sitting on 1.44B for the twelve trailing months.

Volume

Today’s last reported volume for CNOVA is 1051 which is 7.46% above its average volume of 978.

More news about CNOVA.

5. PIERRE VAC BSA ACT (VACBS.PA)

-9.76% Price Change

CAC 40 ended the session with PIERRE VAC BSA ACT falling 9.76% to €0.15 on Tuesday while CAC 40 fell 0.21% to €7,250.13.

More news about PIERRE VAC BSA ACT.

6. SOLOCAL GROUP (LOCAL.PA)

-8.81% Price Change

Solocal Group S.A. provides digital services in France and internationally. Its services include connect that allows VSEs and SMEs to manage their digital presence on PagesJaunes and various mobile application or a web interface, as well as manages interactions between professionals and their customers; and booster that allows companies to increase their digital visibility in the Web. The company was formerly known as PagesJaunes Groupe and changed its name to SoLocal Group S.A. in June 2013. Solocal Group S.A. was founded in 1896 and is headquartered in Boulogne-Billancourt, France.

CAC 40 ended the session with SOLOCAL GROUP dropping 8.81% to €0.09 on Tuesday while CAC 40 slid 0.21% to €7,250.13.

Earnings Per Share

As for profitability, SOLOCAL GROUP has a trailing twelve months EPS of €-0.28.

Revenue Growth

Year-on-year quarterly revenue growth declined by 7.5%, now sitting on 384.78M for the twelve trailing months.

Yearly Top and Bottom Value

SOLOCAL GROUP’s stock is valued at €0.09 at 21:40 EST, way under its 52-week high of €0.73 and way higher than its 52-week low of €0.08.

Moving Average

SOLOCAL GROUP’s worth is way under its 50-day moving average of €0.11 and way under its 200-day moving average of €0.27.

More news about SOLOCAL GROUP.

7. UBISOFT ENTERTAIN (UBI.PA)

-7.95% Price Change

Ubisoft Entertainment SA produce, publishes, and distributes video games for consoles, PC, smartphones, and tablets in both physical and digital formats in Europe, North America, and internationally. The company designs and develops software, including scenarios, animation, gameplay, layouts, and game rules, as well as develops design tools and game engines. It is involved in the development in the area of online and mobile gaming; and film business. Ubisoft Entertainment SA was incorporated in 1986 and is headquartered in Saint-Mandé, France.

CAC 40 ended the session with UBISOFT ENTERTAIN dropping 7.95% to €27.08 on Tuesday while CAC 40 dropped 0.21% to €7,250.13.

Earnings Per Share

As for profitability, UBISOFT ENTERTAIN has a trailing twelve months EPS of €-2.78.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -20.11%.

Revenue Growth

Year-on-year quarterly revenue growth grew by 14.3%, now sitting on 1.92B for the twelve trailing months.

Yearly Top and Bottom Value

UBISOFT ENTERTAIN’s stock is valued at €27.08 at 21:40 EST, way under its 52-week high of €31.60 and way higher than its 52-week low of €18.06.

Volatility

UBISOFT ENTERTAIN’s last week, last month’s, and last quarter’s current intraday variation average was a negative 0.71%, a positive 0.38%, and a positive 1.90%.

UBISOFT ENTERTAIN’s highest amplitude of average volatility was 0.72% (last week), 1.29% (last month), and 1.90% (last quarter).

More news about UBISOFT ENTERTAIN.

8. NEL (NEL.OL)

-7.88% Price Change

Nel ASA, a hydrogen company, provides various solutions to produce, store, and distribute hydrogen from renewable energy in Norway and internationally. The company operates in two segments, Nel Hydrogen Fueling and Nel Hydrogen Electrolyser. The Nel Hydrogen Fueling segment produces H2Station hydrogen fueling stations that provide fuel cell electric vehicles with the fueling and long range as conventional fossil fuel vehicles, include cars, buses, trucks, and other applications. The Nel Hydrogen Electrolyser segment supplies hydrogen production equipment based on alkaline and proton exchange membrane water electrolysis technology. It serves industry, energy, and gas companies. The company was formerly known as DiaGenic ASA and changed its name to Nel ASA in October 2014. Nel ASA was founded in 1927 and is headquartered in Oslo, Norway.

Oslo Børs Benchmark Index_GI ended the session with NEL dropping 7.88% to €7.22 on Tuesday, following the last session’s upward trend. Oslo Børs Benchmark Index_GI dropped 0.87% to €1,299.85, following the last session’s downward trend on what was a somewhat down trend trading session today.

Earnings Per Share

As for profitability, NEL has a trailing twelve months EPS of kr-0.93.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -23.62%.

Earnings Before Interest, Taxes, Depreciation, and Amortization

NEL’s EBITDA is 6.08.

More news about NEL.

9. BENEVOLENTAI (BAI.AS)

-7.69% Price Change

BenevolentAI S.A. operates as a clinical-stage AI-enabled drug discovery and development company. Its BenevolentAI platform powers in-house drug pipeline of drug programs. The company's therapeutic areas, include atopic dermatitis, ulcerative colitis, amyotrophic lateral sclerosis, glioblastoma multiforme, inflammatory bowel disease, antiviral, oncology, parkinson's disease, nonalcoholic steatohepatitis, fibrosis, inflammation, chronic kidney disease, and idiopathic pulmonary fibrosis. It has a collaboration with AstraZeneca to enhance understanding of complex disease biology and identify new targets. The company was founded in 2013 and is headquartered in London, United Kingdom.

AEX-Index ended the session with BENEVOLENTAI sliding 7.69% to €0.60 on Tuesday while AEX-Index slid 0.37% to €761.37.

Earnings Per Share

As for profitability, BENEVOLENTAI has a trailing twelve months EPS of €-0.47.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -40.97%.

Volume

Today’s last reported volume for BENEVOLENTAI is 2401 which is 57.26% below its average volume of 5618.

Yearly Top and Bottom Value

BENEVOLENTAI’s stock is valued at €0.60 at 21:40 EST, under its 52-week low of €0.61.

Volatility

BENEVOLENTAI’s last week, last month’s, and last quarter’s current intraday variation average was a positive 0.40%, a negative 2.77%, and a positive 4.51%.

BENEVOLENTAI’s highest amplitude of average volatility was 2.76% (last week), 5.68% (last month), and 4.51% (last quarter).

Moving Average

BENEVOLENTAI’s value is way under its 50-day moving average of €0.88 and way below its 200-day moving average of €1.64.

More news about BENEVOLENTAI.

10. CARASENT (CARA.OL)

-7.65% Price Change

Carasent ASA provides cloud-based medical record services to the health care industry in the Nordic region. The company offers Webdoc, a digital electronic health record (EHR) system; Vårdrummet, a digital platform for communication between patients and therapists, as well as care givers; and Ad Curis, a journal and professional system that delivers forward-thinking services to rehabilitation, substance abuse treatment, and mental health care, as well as organizations within upbringing and preventive works. It also provides Metodika EPM, a solution for medium sized private clinics and hospitals; Medrave M4, a program that offers healthcare professionals with an overview of the patient treatment group; Confrere, a video solution for physicians; and Plustoo, a software solution that collects, analyses, and visualizes data, as well as enables occupational health providers, employers, and employees to collaborate for healthy and sustainable work environment. In addition, the company provides Ad Voca; and Ad Opus, a system that structures work processes to follow-up participants in a course of measures for companies that work with inclusion into working life. Carasent ASA was formerly known as Apptix ASA and changed its name to Carasent ASA in May 2019. The company was founded in 1997 and is based in Oslo, Norway.

Oslo Børs Benchmark Index_GI ended the session with CARASENT falling 7.65% to €10.38 on Tuesday while Oslo Børs Benchmark Index_GI dropped 0.87% to €1,299.85.

Earnings Per Share

As for profitability, CARASENT has a trailing twelve months EPS of kr-0.8.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -4.05%.

Earnings Before Interest, Taxes, Depreciation, and Amortization

CARASENT’s EBITDA is 2.54.

More news about CARASENT.

Stay up to date with our winners and losers daily report